Lamivudine and Zidovudine

Product NDC

69097-315

11-digit product format

690970315

Labeler code

69097

Product ID

69097-315_c360bd83-8e40-4dcf-9d91-1949a99e775c

Type

HUMAN PRESCRIPTION DRUG

Nonproprietary name

Lamivudine and Zidovudine

Dosage form

TABLET, FILM COATED

Route

ORAL

Labeler

Cipla USA Inc.

Application

ANDA077411

Marketing category

ANDA

Marketing start

2018-09-07

Marketing end

0000-00-00

Substance

LAMIVUDINE; ZIDOVUDINE

Active strength

150 mg/1; mg/1

Pharmacologic classes

Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [EXT],Nucleoside Reverse Transcriptase Inhibitors [MoA],Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [EXT],Nucleoside Reverse Transcriptase Inhibitors [MoA]

NDC exclude flag

No

Listing certified through

2019-12-31

Current FDA listing

Historical FDA.report record